Detection of Urinary Human Chorionic Gonadotropin (hCG)
- Conditions
- Pregnancy Detection
- Registration Number
- NCT05458778
- Lead Sponsor
- Quanovate Tech Inc.
- Brief Summary
- The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study. 
- Detailed Description
- The studies include two parts, which are a lay user study and a urine samples test during the trying to conceive cycle. 
 Part 1: Lay user study Part 2: Detection of hCG in Early Pregnancy Clinical Samples
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 200
- Female
- Aged 18 and over
- Willing to give informed consent
- Willing to conduct a personal home pregnancy test and reveal their pregnancy status
- Have a working smartphone
- Have a medical background or have been in a related industry/occupation
- Volunteers who are unfit to participate in the research by the researcher
- Used the investigational pregnancy test previously
- Has a medical condition
- Confirmed to be pregnant by a healthcare professional and beyond the first trimester (defined as last menstrual period (LMP) +13 weeks)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Cognitive evaluation via survey and calculating the consistency - From July 2022 to August 2022 - The consistency between the lay-user test results and the actual test results - The accuracy of data was expressed as per the Pregnancy Detection Rate - From July 2022 to August 2022 - The number of positive results on different days obtained by the user of the Mira pregnancy test is divided by the total number of women who confirmed pregnancy. 
- Secondary Outcome Measures
- Name - Time - Method 
Trial Locations
- Locations (1)
- Quanovate Tech Inc. 🇺🇸- San Ramon, California, United States Quanovate Tech Inc.🇺🇸San Ramon, California, United StatesZheng Yang, PhDContact
